Brief: PCI Biotech Holding ASA Decided To Stop Release Study

PCI Biotech Holding ASA

24/01/2022 20:04

Jan 24 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :
    * DECIDED TO STOP RELEASE STUDY AND FOCUS THEIR DRUG
DEVELOPMENT
EFFORTS ON PROMISING IMMUNOTHERAPY OPPORTUNITIES
    * PCI BIOTECH - RELEASE TRIAL ENROLLED A TOTAL OF 41
PATIENTS, OF
WHICH AROUND 30% WILL CONTINUE TO RECEIVE STUDY TREATMENTS FOR A
DURATION OF 6 MONTHS

Source text for Eikon:  ID:nGNE1HXfJN 
Further company coverage:  PCIB.OL 

 ((Reuters.Brief@thomsonreuters.com;))